This year’s BEBPA 2025 conference was more than a meeting of minds, it was a mirror reflecting where the field of potency testing is headed. Over three days, we spoke with scientists, QC leaders, and regulatory experts from global innovators such as Johnson & Johnson, Novartis, Novo Nordisk, and many others.
Across conversations, one theme echoed consistently: the need for reliable, mechanism-linked, and reproducible potency assays that can keep up with the pace of innovation in biologics, gene, and cell therapies. Challenges like assay variability, fragile transfer, and lengthy validation cycles continue to slow progress. That’s exactly where Quantum Nuova offers something different.
Quantum Nuova and Potency Assays
Our platform delivers real-time, label-free functional readouts by tracking free radical kinetics—a universal indicator of biological activity. This approach connects potency directly to mechanism of action (MoA), offering rapid, reproducible, and biologically meaningful insights. By reducing reliance on multiple orthogonal assays, Quantum Nuova helps teams generate MoA-reflective potency data with greater confidence and consistency.
At BEBPA, the response to this concept was inspiring. Experts were curious, engaged, and genuinely excited about how this technology could complement existing potency workflows—not replace them, but enhance them with faster, more mechanistic insights.
For us, these discussions validated a simple truth: the industry is ready for potency assays that are fit-for-purpose, robust, and ready to evolve alongside emerging modalities—from monoclonal antibodies and bispecifics to AAV, CAR-T, and mRNA therapies.
Next Step… a Call for Collaboration
Our next step is to turn this momentum into collaboration. At QT Sense, we are building partnerships with pharma and biotech teams who share our vision of faster, smarter, and more biologically grounded potency testing.
Experience the future of potency measurement—live, reproducible, and mechanism-linked.
Reach out for a demonstration or collaboration at www.qtsense.com or [email protected].
Share this:
